Clinical Trial Update: Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers [Phase 1, Phase 2]

View source ↗

Summary

This is an update on Claudin18.2-targeted CAR-T therapy CT041 for gastric and pancreatic cancers (and related digestive cancers), showing phase 1/2 progress wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Pancreatic Cancer

Drugs mentioned

• CT041 (Claudin18.2-targeted CAR-T cell therapy)

Snippet

Sponsor: CARsgen Therapeutics Co., Ltd. | Conditions: Gastric Cancer, Pancreatic Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING